微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 40.69% | 2% | -0.99% | 87/132 | 51.53% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 41.1% | -4.6% | 0.44% | 84/132 | 51.65% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 40.92% | 2% | -3.24% | 86/132 | 51.25% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 42.29% | -3.31% | -1.84% | 87/132 | 52.33% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-06-30 | 43.08% | -0.82% | -1.5% | 87/132 | 53.3% | 佰仁医疗 | 88.56% | 行业排名> |
| 2023-12-31 | 43.74% | 1.94% | 0.69% | 85/132 | 53.31% | 佰仁医疗 | 89.27% | 行业排名> |
| 2023-06-30 | 43.44% | 2% | 1.24% | 89/132 | 53.45% | 佰仁医疗 | 89.28% | 行业排名> |
| 2022-12-31 | 42.91% | -7.64% | -7.64% | 90/132 | 53.83% | 正海生物 | 89.9% | 行业排名> |
| 2021-12-31 | 46.45% | -5.04% | -5.04% | 88/132 | 57.29% | 正海生物 | 90.39% | 行业排名> |
| 2020-12-31 | 48.92% | 2% | 2% | 88/132 | 59.59% | 正海生物 | 90.3% | 行业排名> |